A New Way Forward in Canine Osteoarthritis: Targeting Pain and Inflammation at Its SourceJuly 1, 2025The traditional approach to canine osteoarthritis (OA) has largely focused on treatments such as NSAIDs, joint supplements, stem cell, PRP, and anti-nerve growth factor (anti-NGF) injections. This raises a critical question: What if we could do more than manage symptoms? What if we could target the inflammation driving the disease?
SPONSORED CONTENTAre Your Patients Fully Protected?Fleas, ticks, heartworms, and intestinal parasites—dogs face multiple threats. See how a multi-parasite approach can offer your patients a broad range of protection. + Learn More
A closer look at OA supplements—Part 2May 17, 2025In this installment, we will discuss green-lipped mussel, turmeric, undenatured collagen II, CBD products, and a recent literature review of each active nutraceutical.
A closer look at OA supplements—Part 1March 15, 2025Osteoarthritis (OA) is common in dogs and cats. Often, the practitioner utilizes multimodal approaches to treatment, offering anti-inflammatory medications and dietary supplements. Let's look at some options for your OA patient.
FIP, radiation, and other advances key to practicesAugust 5, 2024It is not always easy keeping up with what is happening and new in veterinary medicine. Four experts share more about recent advances in the field that could affect your practice.
Managing OA requires controlling inflammationMarch 3, 2024While sometimes called an “old dog disease,” canine osteoarthritis (OA) can affect dogs of any age, with risk factors that include breed, intense activity, obesity, join injury, and joint surgery.
Veterinarians call for a 'standard' protocol in canine OA management, survey showsJanuary 4, 2024Ninety-five percent of veterinarians surveyed by the American Animal Hospital Association (AAHA) say standardized care procedures in managing canine OA would be ‘beneficial’
